Loreylys has worked exclusively on patent litigation matters covering a wide variety of technologies and has extensive experience in life sciences litigation. She is skilled in all aspects of case management, with an emphasis on discovery, document collection and production, as well as pre- and post-trial-related work.
Cooley Secures Win for Liquidia to Launch First Product
April 5, 2024
Cooley successfully lifted a Hatch-Waxman injunction for Liquidia Technologies, a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products, enabling Liquidia to launch its new drug, Yutrepia.
